Brand Name

Mycobutin

Generic Name
Rifabutin
View Brand Information
FDA approval date: December 23, 1992
Classification: Rifamycin Antimycobacterial
Form: Capsule

What is Mycobutin (Rifabutin)?

Rifabutin Capsules are indicated for the prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infection.

Approved To Treat

Top Global Experts

There are no experts for this drug

Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

There is no clinical trials being done for this treatment

Related Latest Advances

There is no latest advances for this treatment